DiaSorin S.p.A. (OTCMKTS:DSRLF – Get Free Report) saw a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 312,900 shares, a decline of 35.7% from the June 30th total of 486,900 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.
DiaSorin Price Performance
Shares of DSRLF stock remained flat at $99.86 during mid-day trading on Monday. DiaSorin has a 1-year low of $86.00 and a 1-year high of $109.00. The business’s fifty day moving average price is $105.16 and its 200-day moving average price is $99.17.
Wall Street Analyst Weigh In
Separately, Barclays initiated coverage on DiaSorin in a research note on Thursday, May 9th. They set an “equal weight” rating on the stock.
About DiaSorin
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.
See Also
- Five stocks we like better than DiaSorin
- What is an Earnings Surprise?
- Survey: Top 175 Fittest Retirement Locations in America
- Stock Average Calculator
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- What is Insider Trading? What You Can Learn from Insider Trading
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.